AU2003234035A1 - Specific genetic markets for cytogenetically defined acute myeloid leukaemia - Google Patents

Specific genetic markets for cytogenetically defined acute myeloid leukaemia

Info

Publication number
AU2003234035A1
AU2003234035A1 AU2003234035A AU2003234035A AU2003234035A1 AU 2003234035 A1 AU2003234035 A1 AU 2003234035A1 AU 2003234035 A AU2003234035 A AU 2003234035A AU 2003234035 A AU2003234035 A AU 2003234035A AU 2003234035 A1 AU2003234035 A1 AU 2003234035A1
Authority
AU
Australia
Prior art keywords
acute myeloid
specific genetic
myeloid leukaemia
defined acute
markets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003234035A
Other versions
AU2003234035A8 (en
Inventor
Silvana Debernardi
Simon Roy Tomlinson
Bryan Douglas Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Technology Ltd
Original Assignee
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Technology Ltd filed Critical Cancer Research Technology Ltd
Publication of AU2003234035A8 publication Critical patent/AU2003234035A8/en
Publication of AU2003234035A1 publication Critical patent/AU2003234035A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
AU2003234035A 2002-05-31 2003-05-28 Specific genetic markets for cytogenetically defined acute myeloid leukaemia Abandoned AU2003234035A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38506502P 2002-05-31 2002-05-31
US60/385,065 2002-05-31
PCT/GB2003/002315 WO2003102235A2 (en) 2002-05-31 2003-05-28 Specific genetic markets for cytogenetically defined acute myeloid leukaemia

Publications (2)

Publication Number Publication Date
AU2003234035A8 AU2003234035A8 (en) 2003-12-19
AU2003234035A1 true AU2003234035A1 (en) 2003-12-19

Family

ID=29712131

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003234035A Abandoned AU2003234035A1 (en) 2002-05-31 2003-05-28 Specific genetic markets for cytogenetically defined acute myeloid leukaemia

Country Status (2)

Country Link
AU (1) AU2003234035A1 (en)
WO (1) WO2003102235A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005214286A1 (en) * 2004-02-23 2005-09-01 Erasmus University Medical Center Rotterdam Classification, diagnosis and prognosis of acute myeloid leukemia by gene expression profiling
CN101156067A (en) * 2005-02-16 2008-04-02 惠氏公司 Methods and systems for diagnosis, prognosis and selection of treatment of leukemia
WO2006119494A2 (en) * 2005-05-04 2006-11-09 Exagen Diagnostics, Inc. Acute myelogenous leukemia biomarkers
CN113136432A (en) * 2021-05-06 2021-07-20 杭州艾迪康医学检验中心有限公司 Reagent and method for detecting relative expression quantity of PRAME gene in AML

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993012136A1 (en) * 1991-12-11 1993-06-24 Thomas Jefferson University Detection and treatment of acute leukemias resulting from chromosome abnormalities in the all-1 region
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
EP1308522A1 (en) * 2001-11-05 2003-05-07 Haferlach, Torsten, PD Dr. Dr. Novel genetic markers for leukemias

Also Published As

Publication number Publication date
WO2003102235A2 (en) 2003-12-11
AU2003234035A8 (en) 2003-12-19
WO2003102235A3 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
AU2002365110A1 (en) Small molecule microarrays
AU2003262881A1 (en) Temperature-controlled substrate holder
AU2003294570A1 (en) Sign holder
AU2003269920A1 (en) Jewelry holder
AU2003259954A1 (en) Dedicated high priority access channel
AU2003243163A1 (en) Sample carrier system
AU2003280484A1 (en) Slide show with audio
AU2003234301A1 (en) Diamond synthesis
AU2003202881A1 (en) Instrument cluster
AU2003209021A1 (en) Slot die
AU2003299281A1 (en) Cooling channel geometry
AU2003256991A1 (en) Sample holder
AU2003298649A1 (en) Feeding processes for fermentation
AU2003201418A1 (en) Trim hardware carrier
AU2003264488A1 (en) Immunotherapeutic for cancer
AU2003273640A1 (en) Autism gene
AU2003234035A1 (en) Specific genetic markets for cytogenetically defined acute myeloid leukaemia
AU2003272964A1 (en) Remedy for hormone-dependent cancer
AU2003274519A1 (en) Cigarette-pack holder
AU2003297122A1 (en) Label holder
AU2003265610A1 (en) Die carrier
AU2003290284A1 (en) Deformable-mirror holder
AU2003259874A1 (en) Sign holder
AU2003285880A1 (en) Label holder for moist environments
AU2003220217A1 (en) Identifying peptide modifications

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase